Steris (STE) Construction in Progress (2018 - 2026)
Steris' (STE) quarterly Construction in Progress came in at $509.5 million in Q1 2026, down 0.51% year-on-year from $512.1 million in Q1 2025, and down 13.14% quarter-over-quarter from $586.6 million in Q4 2025.
Steris (STE) Construction in Progress (2018 - 2026) Analysis & Trends
Steris' Construction in Progress history runs 9 years deep, the most recent figure standing at $509.5 million for Q1 2026.
- On a quarterly basis, Construction in Progress fell 0.51% year-over-year to $509.5 million in Q1 2026; TTM through Mar 2026 was $509.5 million, a 0.51% decrease from a year earlier, with the FY2026 full-year figure at $509.5 million, down 0.51% from the prior year.
- Construction in Progress retreated to $509.5 million in Q1 2026 per STE's latest filing, from $586.6 million in the prior quarter.
- Across five years, Construction in Progress topped out at $586.6 million in Q4 2025 and bottomed at $356.0 million in Q1 2022.
- The 5-year median for Construction in Progress is $509.5 million (2026), against an average of $496.8 million.
- Across the five-year window, Construction in Progress surged 68.42% in 2022 and slipped 0.96% in 2025, its largest moves.
- Year by year, Construction in Progress stood at $489.8 million in 2022, then grew by 4.61% to $512.4 million in 2023, then fell by 0.5% to $509.8 million in 2024, then advanced by 15.06% to $586.6 million in 2025, then retreated by 13.14% to $509.5 million in 2026.
- Per Business Quant, the three latest STE Construction in Progress figures stand at $509.5 million (Q1 2026), $586.6 million (Q4 2025), and $571.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.52 Bn | 175.22 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.96 Bn | 126.09 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.99 Bn | 98.77 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 67.76 Bn | 66.31 Bn | 3.61 Bn | 1.12 Bn |
| 5 | Edwards Lifesciences | 48.09 Bn | 44.41 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.30 Bn | 27.18 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.89 Bn | 25.61 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 27.02 Bn | 26.45 Bn | - | - |
| 9 | Koninklijke Philips | 23.98 Bn | 20.86 Bn | 2.07 Bn | - |
| 10 | Steris | 21.45 Bn | 21.01 Bn | 697.10 Mn | 509.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 509.50 Mn |
| Dec 31, 2025 | 586.60 Mn |
| Sep 30, 2025 | 571.90 Mn |
| Jun 30, 2025 | 560.90 Mn |
| Mar 31, 2025 | 512.10 Mn |
| Dec 31, 2024 | 509.80 Mn |
| Sep 30, 2024 | 577.44 Mn |
| Jun 30, 2024 | 522.83 Mn |
| Mar 31, 2024 | 500.11 Mn |
| Dec 31, 2023 | 512.37 Mn |
| Sep 30, 2023 | 467.13 Mn |
| Jun 30, 2023 | 464.41 Mn |
| Mar 31, 2023 | 472.21 Mn |
| Dec 31, 2022 | 489.77 Mn |
| Sep 30, 2022 | 429.68 Mn |
| Jun 30, 2022 | 402.80 Mn |
| Mar 31, 2022 | 356.01 Mn |
| Dec 31, 2021 | 341.04 Mn |
| Sep 30, 2021 | 282.31 Mn |
| Jun 30, 2021 | 274.41 Mn |